T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDC
1676
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.18M | ﹤0.01% |
39,043
+4,834
| +14% | +$246K |
|
|
LMST
1677
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $2.17M | ﹤0.01% |
116,519
| – | – |
|
|
TGNA
1678
DELISTED
TEGNA Inc
TGNA
| $2.16M | ﹤0.01% |
116,202
+1,893
| +2% | +$37.9K |
|
1679
Futu Holdings
FUTU
$14.6B
| $2.14M | ﹤0.01% |
49,417
+42,317
| +596% | +$2.42M |
|
|
CSR
1680
Centerspace
CSR
$941M
| $2.14M | ﹤0.01% |
19,290
+2,006
| +12% | +$207K |
|
1681
United Natural Foods
UNFI
$2.92B
| $2.14M | ﹤0.01% |
43,562
-3,351
| -7% | -$162K |
|
1682
Hawaiian Electric Industries
HE
$2.06B
| $2.13M | ﹤0.01% |
51,451
-1,744
| -3% | -$70.8K |
|
1683
Fluor
FLR
$7.12B
| $2.13M | ﹤0.01% |
86,032
-12,802
| -13% | -$272K |
|
|
DEN
1684
DELISTED
Denbury Inc.
DEN
| $2.12M | ﹤0.01% |
27,726
+7,288
| +36% | +$577K |
|
1685
Spire
SR
$4.89B
| $2.11M | ﹤0.01% |
32,345
-1,942
| -6% | -$123K |
|
1686
Commercial Metals
CMC
$7.99B
| $2.11M | ﹤0.01% |
58,127
-1,425
| -2% | -$47.2K |
|
|
ARNA
1687
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.11M | ﹤0.01% |
22,659
-7,572
| -25% | -$499K |
|
1688
State Street SPDR S&P 500 ETF Trust
SPY
$814B
| $2.1M | ﹤0.01% |
4,420
-191
| -4% | -$87.7K |
|
|
RDFN
1689
DELISTED
Redfin
RDFN
| $2.1M | ﹤0.01% |
54,564
-751,588
| -93% | -$34.1M |
|
1690
Donaldson
DCI
$11.1B
| $2.09M | ﹤0.01% |
35,262
-3,094
| -8% | -$183K |
|
1691
UMB Financial
UMBF
$11.5B
| $2.09M | ﹤0.01% |
19,675
-738
| -4% | -$76.1K |
|
1692
Signet Jewelers
SIG
$3.5B
| $2.09M | ﹤0.01% |
23,965
-3,069
| -11% | -$282K |
|
1693
Black Hills Corp
BKH
$5.66B
| $2.08M | ﹤0.01% |
29,429
-2,350
| -7% | -$156K |
|
1694
Crane NXT
CXT
$2.98B
| $2.07M | ﹤0.01% |
58,536
-1,701
| -3% | -$59.1K |
|
1695
Interactive Brokers
IBKR
$41.7B
| $2.07M | ﹤0.01% |
104,132
-6,272
| -6% | -$117K |
|
1696
Bank OZK
OZK
$5.73B
| $2.07M | ﹤0.01% |
44,411
-2,124
| -5% | -$96.9K |
|
1697
Park Hotels & Resorts
PK
$3.05B
| $2.06M | ﹤0.01% |
109,364
-6,214
| -5% | -$117K |
|
1698
KBR
KBR
$4.84B
| $2.06M | ﹤0.01% |
43,346
-2,388
| -5% | -$105K |
|
1699
Harley-Davidson
HOG
$2.91B
| $2.06M | ﹤0.01% |
54,657
-4,497
| -8% | -$168K |
|
1700
Sprout Social
SPT
$597M
| $2.06M | ﹤0.01% |
22,675
+8,582
| +61% | +$973K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.